Please log in to see the full text of this API!
Amlodipine
-
ATC:
C08CA01
-
Use:
Lorem
Lorem
-
Chemical name:
Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:408.88 g/mol
-
CAS-RN:88150-42-9
-
InChI Key:HTIQEAQVCYTUBX-UHFFFAOYSA-N
-
InChI:InChI=1S/C20H25ClN2O5/c1-4-28-20(25)18-15(11-27-10-9-22)23-12(2)16(19(24)26-3)17(18)13-7-5-6-8-14(13)21/h5-8,17,23H,4,9-11,22H2,1-3H3
Derivatives
maleate (1:1)
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:524.95 g/mol
-
CAS-RN:88150-47-4
besylate (benzenesulfonate)
-
Use:
-
Formula:
Lorem ipsum dolor sit amet,
-
MW:567.06 g/mol
-
CAS-RN:111470-99-6
Substances Referenced in Synthesis Path
CAS-RN |
Formula |
Chemical Name |
CAS Index Name |
1517-05-1 |
C2H5N3O |
2-azidoethanol |
Ethanol, 2-azido- |
89-98-5 |
C7H5ClO |
o-chlorobenzaldehyde |
Benzaldehyde, 2-chloro- |
88150-45-2 |
C8H13N3O4 |
ethyl 4-(2-azidoethoxy)acetoacetate |
Butanoic acid, 4-(2-azidoethoxy)-3-oxo-, ethyl ester |
638-07-3 |
C6H9ClO3 |
ethyl 4-chloroacetoacetate |
Butanoic acid, 4-chloro-3-oxo-, ethyl ester |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Lorem |
Trade Names
Country |
Trade Name |
Vendor |
Annotation |
D |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
Lorem
|
|
Lorem ipsum |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
Lorem
Lorem
|
|
Lorem ipsum dolor |
|
|
F |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
comb. |
Lorem |
Lorem
|
|
GB |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
I |
Lorem |
Lorem
,1991 |
|
Lorem |
Lorem
,1991 |
|
Lorem |
Lorem
|
|
J |
Lorem |
Lorem
Lorem
|
|
Lorem |
Lorem
|
|
USA |
Lorem |
Lorem
|
|
Lorem |
Lorem
|
|
Lorem |
Lorem
,1991 |
|
(wfm = withdrawn from market)
Formulations
- Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumyeirmodtemporinvidunt
References
-
- US 9 999 999 (Pfizer; 25.2.1986; GB-prior. 11.3.1982).
- EP 99 999 (Pfizer; appl. 8.3.1983; GB-prior. 11.3.1982).
- EP 999 999 (Lek; appl. 19.11.1993; SI-prior. 26.11.1992).
- CA 9 999 999 (Apotex; appl. 17.10.1996; NZ-prior. 1.11.1995).
-
besylate salt:
- EP 999 999 (Pfizer; appl. 31.3.1987; GB-prior. 4.4.1986).
- US 9 999 999 (Pfizer; 7.11.1989; GB-prior. 4.4.1986).
-
racemate resolution:
- EP 999 999 (Pfizer; appl. 16.2.1989; GB-prior. 27.2.1988).
- Arrowsmith, J.E. et al.: J. Med. Chem. (JMCMAR) 29, 9999 (1986).
-
combination with ACE-inhibitors:
- WO 9 999 999 (Pfizer; appl. 26.2.1996; USA-prior. 16.3.1995).